The relative frequency of salmonella strains isolated from hospitalized
and non-hospitalized
patients in Southern Israel changed during the period, 1994–6. Salmonella
enterica serotype
Typhimurium definitive phage-type 104 (DT104) appeared in Israel in 1994
and became the
most prevalent strain in 1996. An outbreak of enteritis due to Salmonella
enterica serotype
Agona occurred in Israel, in October 1994 and lasted for 4 months. The
relative frequency of
Salmonella enterica serotype Enteritidis remained almost constant
during these years, with
seasonal fluctuations only.
The importance of the increase in the prevalence of Typhimurium DT104
has been the
epidemic spread of a multiresistant strain of R-type ACT (A, ampicillin;
C, chloramphenicol;
T, tetracycline) belonging to this phage-type. Since 1995 the frequency
of Typhimurium DT104
isolates that possess, in addition to the above R-type, a chromosomally
encoded resistance to
the quinolone drug, nalidixic acid, increased tenfold. In 1996, 27% of
the Typhimurium DT104
isolates were of R-type ACTN. S. Enteritidis exhibited over 95%
susceptibility to at least eight
of the most commonly used antibiotic drugs, and none of the isolates was
resistant to
quinolone or fluoroquinoline.